Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Burning Rock Biotech (BNR) over the last 6 years, with Q2 2025 value amounting to $279000.0.

  • Burning Rock Biotech's Cash from Financing Activities changed N/A to $279000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$6.3 million, marking a year-over-year change of. This contributed to the annual value of -$10000.0 for FY2024, which is 9985.46% up from last year.
  • According to the latest figures from Q2 2025, Burning Rock Biotech's Cash from Financing Activities is $279000.0.
  • Burning Rock Biotech's Cash from Financing Activities' 5-year high stood at $279000.0 during Q2 2025, with a 5-year trough of -$12.5 million in Q4 2022.
  • For the 5-year period, Burning Rock Biotech's Cash from Financing Activities averaged around -$2.8 million, with its median value being -$628000.0 (2021).
  • Data for Burning Rock Biotech's Cash from Financing Activities shows a peak YoY increase of 9919.48% (in 2023) and a maximum YoY decrease of 157706.67% (in 2023) over the last 5 years.
  • Over the past 5 years, Burning Rock Biotech's Cash from Financing Activities (Quarter) stood at -$1.1 million in 2021, then crashed by 1073.99% to -$12.5 million in 2022, then soared by 97.85% to -$269000.0 in 2023, then skyrocketed by 96.28% to -$10000.0 in 2024, then soared by 2890.0% to $279000.0 in 2025.
  • Its Cash from Financing Activities stands at $279000.0 for Q2 2025, versus -$10000.0 for Q4 2024 and -$269000.0 for Q4 2023.